DeHeng Advised Jianzhijia on Obtaining CSRC Approval

for Private Placement of Shares

2022-03-09

On March 7, 2022, the application of Yunnan Jianzhijia Health Drug Store Chain Co., Ltd. (“Jianzhijia,” stock code: 600096) for non-public offering of shares was unconditionally approved by the Public Offering Review Committee of China Securities Regulatory Commission (CSRC). 

As the legal counsel for the issuance, the DeHeng team, led by partners Wu Zhixu and Wang Lin, with primary support from attorneys Liu Shuhan and Yu Tian and Li Yan, worked closely and actively with the issuer and other intermediary agencies and provided professional, high-quality and efficient legal services for the client.